Based on data collected from different sources by our team,
there are indicators that suggest that this company is no longer active. However, this information may not be accurate.
If you believe this information should be updated, please .
For more details, you can read our .
Canopy is a pre-clinical stage biotech developing a new class of biologics that will allow the elimination of antigen-specific immunity, providing non-immunosuppressive, potentially curing treatments to many dozens of autoimmune, allergic, and other antibody-mediated conditions using its proprietary Reverse-Immunization platform.
Locations
Israel
Offices Abroad
Canopy Immuno-Therapeutics Climate Tech relevance
undefined
Recent News
No Data, yet.
Sorry, no content found under this section.
Photos & Videos
(1)
No Data, yet.
Sorry, no content found under this section.
Ep421: Kfir Oved | Founder and CEO, Canopy Immuno-therapeutics